Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Equity Income (2024 - 2025)

Historic Equity Income for Tandem Diabetes Care (TNDM) over the last 2 years, with Q3 2025 value amounting to -$2.7 million.

  • Tandem Diabetes Care's Equity Income changed N/A to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.8 million, marking a year-over-year change of. This contributed to the annual value of -$2.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Tandem Diabetes Care reported Equity Income of -$2.7 million as of Q3 2025.
  • In the past 5 years, Tandem Diabetes Care's Equity Income ranged from a high of -$2.1 million in Q4 2024 and a low of -$3.5 million during Q1 2025